We have more good news about a coronavirus vaccine
A coronavirus vaccine candidate from Novavax completed its Phase 1 trial with promising results. The NVX-CoV2373 drug induced neutralizing antibodies in all the volunteers who …
NVX-CoV2373
Latest NVX-CoV2373
We have more good news about a coronavirus vaccine
A coronavirus vaccine candidate from Novavax completed its Phase 1 trial with promising results. The NVX-CoV2373 drug induced neutralizing antibodies in all the volunteers who …
